Query

Active Filters

  • (-) PSI Laboratories = Radiochemistry LRC
  • (-) Keywords = prostate cancer
Search Results 1 - 6 of 6
  • RSS Feed
Select Page
Albumin-binding and conventional PSMA ligands in combination with <sup>161</sup>Tb: biodistribution, dosimetry, and preclinical therapy
Tschan, V. J., Busslinger, S. D., Bernhardt, P., Grundler, P. V., Zeevaart, J. R., Köster, U., … Müller, C. (2023). Albumin-binding and conventional PSMA ligands in combination with 161Tb: biodistribution, dosimetry, and preclinical therapy. Journal of Nuclear Medicine, 64(10), 1625-1631. https://doi.org/10.2967/jnumed.123.265524
Dosimetric analysis of the short-ranged particle emitter <sup>161</sup>Tb for radionuclide therapy of metastatic prostate cancer
Bernhardt, P., Svensson, J., Hemmingsson, J., van der Meulen, N. P., Zeevaart, J. R., Konijnenberg, M. W., … Kindblom, J. (2021). Dosimetric analysis of the short-ranged particle emitter 161Tb for radionuclide therapy of metastatic prostate cancer. Cancers, 13(9), 2011 (13 pp.). https://doi.org/10.3390/cancers13092011
Preclinical investigations and first-in-human application of &lt;sup&gt;152&lt;/sup&gt;Tb-PSMA-617 for PET/CT imaging of prostate cancer
Müller, C., Singh, A., Umbricht, C. A., Kulkarni, H. R., Johnston, K., Benešová, M., … Baum, R. P. (2019). Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer. EJNMMI Research, 9(1), 68 (10 pp.). https://doi.org/10.1186/s13550-019-0538-1
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
Müller, C., Umbricht, C. A., Gracheva, N., Tschan, V. J., Pellegrini, G., Bernhardt, P., … van der Meulen, N. P. (2019). Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1919-1930. https://doi.org/10.1007/s00259-019-04345-0
Targeted &lt;sup&gt;64&lt;/sup&gt;Cu-labeled gold nanoparticles for dual imaging with positron emission tomography and optical imaging
Pretze, M., van der Meulen, N.  P., Wängler, C., Schibli, R., & Wängler, B. (2019). Targeted 64Cu-labeled gold nanoparticles for dual imaging with positron emission tomography and optical imaging. Journal of Labelled Compounds and Radiopharmaceuticals, 62(8), 471-482. https://doi.org/10.1002/jlcr.3736
Design and preclinical evaluation of an albumin-binding PSMA ligand for &lt;sup&gt;64&lt;/sup&gt;Cu-based PET imaging
Umbricht, C. A., Benešová, M., Hasler, R., Schibli, R., van der Meulen, N. P., & Müller, C. (2018). Design and preclinical evaluation of an albumin-binding PSMA ligand for 64Cu-based PET imaging. Molecular Pharmaceutics, 15(12), 5556-5564. https://doi.org/10.1021/acs.molpharmaceut.8b00712